Reem Smoum

Title: Reem Smoum: Innovator in Cannabidiolic Acid Research

Introduction

Reem Smoum is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of cannabinoid research, particularly focusing on the therapeutic applications of cannabidiolic acid esters. With a total of 3 patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

Among her latest patents is a groundbreaking invention related to cannabidiolic acid esters compositions and their uses. This patent outlines the compositions comprising cannabidiolic acid esters and their applications in treating various diseases, conditions, and symptoms. Another notable patent focuses on methods for the treatment of Prader-Willi syndrome. This invention provides pharmaceutical compositions that include a fatty acid amide of an amino acid, such as oleoyl-α-methyl-serine, aimed at improving bone mineral density and treating osteoporosis in patients suffering from Prader-Willi syndrome.

Career Highlights

Reem Smoum has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and the University of Guelph. Her career reflects a commitment to advancing research in cannabinoid applications and their therapeutic benefits.

Collaborations

Throughout her career, Reem has collaborated with notable figures in the field, including Raphael Mechoulam and Joseph Tam. These collaborations have further enriched her research and contributed to her innovative work.

Conclusion

Reem Smoum's contributions to cannabinoid research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for new therapeutic approaches to various medical conditions.